Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

NCT02945176 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft vs Host Disease
Congenital Aniridia
Chemical Burns
Stevens-Johnson Syndrome
Congenital Glaucoma

Interventions

DEVICE: ARGOS-IO system

Sponsor

Implandata Ophthalmic Products GmbH